Evidence map›Paper›PMID 42717101›Full record

ArticleInternational journal of legal medicine2026

Differentiating therapeutic use and potential impairment in the forensic interpretation of valsartan concentrations in road traffic offenders.

Marek Dziadosz, Lisa Marquenie, Wolfgang Rosenberger, Michael Klintschar, Jörg Teske

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marek DziadoszInstitute of Legal Medicine, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, Hannover, D-30625, Germany. Dziadosz.Marek@mh-hannover.de.
Lisa MarquenieInstitute of Legal Medicine, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, Hannover, D-30625, Germany.
Wolfgang RosenbergerInstitute of Legal Medicine, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, Hannover, D-30625, Germany.
Michael KlintscharInstitute of Legal Medicine, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, Hannover, D-30625, Germany.
Jörg TeskeInstitute of Legal Medicine, Hannover Medical School (MHH), Carl-Neuberg-Str. 1, Hannover, D-30625, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on the presented case, general challenges in the interpretation of cardiovascular drug concentrations in the context of active participation in road traffic are discussed. Particular emphasis is placed on the assessment of valsartan concentrations, for which no clearly defined threshold between therapeutic and toxic ranges has been established. The case of a 59‑year‑old male who experienced a medical incident while driving enabled the identification of a valsartan concentration of 12.7 µg/mL, which was well above the expected range. Potential interactions with concomitantly administered medications are also considered.

Indexed as

Cardiovascular medicationIntoxicationLC-MS/MSRoad traffic accidentValsartan

Identifiers

PMID42717101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.